Cinclus Pharma participates at Avanza's Börsdag
Cinclus Pharma's CEO Christer Ahlberg, will talk about the company's latest updates and the development of linaprazan glurate at Avanza's Börsdag on May 22nd.
Read more
News
Check out the latest news from Cinclus Pharma
Cinclus Pharma at Redeye Investor Forum 2024
Christer Ahlberg, CEO of Cinclus Pharma, was invited to present the company's latest updates and the development of linaprazan glurate at the Redeye Investor Forum in Gothenburg on April 18, 2024.
Read more
Cinclus Pharma presented at ABGSC investor days
Cinclus Pharma's CEO, Christer Ahlberg, presented Cinclus Pharma at the ABGCS seminar on November 22-23.
Read more